Close
ACHEMA MIDDLE EAST 2026

Bayer aligns organization with Life Science businesses

Operational management in three divisions: Pharmaceuticals, Consumer Health and Crop Science / Dieter Weinand, Erica Mann and Liam Condon appointed to the Bayer...

Merck Provides Diabetes Portfolio Update and Underscores Comprehensive, Long-Term Commitment to Patients with Diabetes

Presents Pivotal Data for Omarigliptin, Merck’s Investigational Once-Weekly DPP-4 Inhibitor, and Additional Data from the TECOS CV Safety Trial, at European Association for the...

Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference

Bristol-Myers Squibb to Take Part in Deutsche Bank Global Health Care Conference 4/29/15 will take part in the Deutsche Bank Global Health Care Conference on...

Canada’s Valeant buys Salix for $11bn

Canada-based Valeant Pharmaceuticals International has completed the acquisition of US-based Salix Pharmaceuticals for around $11bn.   Under the deal, Valeant has acquired all outstanding...

Neurocrine, Mitsubishi Tanabe to develop VMAT2 inhibitor NBI-98854 for movement disorders

US-based Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement with Japanese firm Mitsubishi Tanabe Pharma to develop and commercialize its VMAT2...

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

Ireland-based Perrigo has completed the acquisition of Belgium's over-the-counter (OTC) drugmaker Omega Pharma for around €3.8bn ($4.5bn).   As part of the deal, Perrigo...

BioCryst gets $35m contract for new Ebola treatment

BioCryst Pharmaceuticals has received a $35m contract to continue developing BCX4430, a drug that has shown early signs of fighting the Ebola virus.  ...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...